BAX and cancer: These findings suggest that HMCLPs induce mitochondrial damage, alter the Bax/Bcl-2 ratio, and activate caspase-3 by increasing intracellular ROS levels, thereby promoting cancer cell apoptosis and demonstrating superior antitumor efficacy compared to free drugs and unmodified nanomedicines.